<DOC>
	<DOCNO>NCT01652599</DOCNO>
	<brief_summary>The purpose study determine response rate response duration combination eltrombopag high-dose dexamethasone</brief_summary>
	<brief_title>Eltrombopag High-dose Dexamethasone First Line Treatment IT</brief_title>
	<detailed_description>Immune Thrombocytopenia autoimmune disorder characterize formation autoantibody platelet antigen lead platelet destruction . Corticosteroids increase platelet count 80 percent patients.However , many patient relapse dose corticosteroid reduce . Debilitating side effect common patient require long-term corticosteroid therapy maintain platelet count . Eltrombopag , small molecule agonist c-mpl ( TpoR ) receptor , physiological target hormone thrombopoietin , show effectively raise platelet count adult patient ( age 18 year ) spleen remove splenectomy option receive prior treatment corticosteroid immunoglobulin , medicine work ( refractary ITP ) . There case report eltrombopag option first line treatment IT . The purpose study determine response rate response duration combination eltrombopag ( 50mg PO day 4 week ) high-dose dexamethasone ( 40mg PO day 1,2,3,4 ) untreated adult patient immune thrombocytopenic patient le 7 day treatment corticosteroid . A complete platelet response define increase platelet count &gt; 150×109/L two consecutive occasion . A partial response define increase platelet count 50 150×109/L two consecutive occasion , 1 week apart . Duration response consider day initial administration first time relapse ( platelet count &lt; 30×109/L ) time analysis . At end first 5 week , patient follow 6 month every month .</detailed_description>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Clinically confirm immune thrombocytopenic ( IT ) Platelet count le 30,000/mm3 two occasion . Platelets &gt; 30000/mm3 bleeding . Less seven day take corticosteroids Normal increase number megakaryocytes bone marrow examination patient ≥ 60 year Subject ≥ 18 year Subject sign dated write informed consent . No sepsis fever No active infection require therapy No active chronic viral infection HIV negative Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Performance status equal 2 . Previous treatment eltrombopag Immunosuppressive treatment within last month Previous splenectomy Presence malignant haematological disease Connective tissue disease Autoimmune hemolytic anemia Pregnancy lactation Not willing participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Eltrombopag</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>High-dose</keyword>
	<keyword>ITP</keyword>
</DOC>